Diagnosis and Management of Nonalcoholic Fatty Liver Disease

被引：7
|
作者：
Leung, Peggy B. [1 ,4 ]
Davis, Andrew M. [2 ]
Kumar, Sonal [3 ]
机构：
[1] Weill Cornell Med, Div Gen Internal Med, New York, NY USA
[2] Univ Chicago, Sect Gen Internal Med, Chicago, IL USA
[3] NewYork Presbyterian Hosp, Weill Cornell Med Ctr, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA
[4] Weill Cornell Med, 505 E 70th St,HT-4, New York, NY 10021 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 17期
关键词：
FIBROSIS; EVENTS;
D O I：
10.1001/jama.2023.17935
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This JAMA Clinical Guidelines Synopsis summarizes the American Association of Clinical Endocrinology's 2022 clinical practice guideline for diagnosis and management of nonalcoholic fatty liver disease.
引用
收藏
页码：1687 / 1688
页数：2
相关论文
共 50 条
  • [31] Nonalcoholic fatty liver disease and aging: Epidemiology to management
    Bertolotti, Marco
    Lonardo, Amedeo
    Mussi, Chiara
    Baldelli, Enrica
    Pellegrini, Elisa
    Ballestri, Stefano
    Romagnoli, Dante
    Loria, Paola
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (39) : 14185 - 14204
  • [32] Nonalcoholic fatty liver disease and aging: Epidemiology to management
    Marco Bertolotti
    Amedeo Lonardo
    Chiara Mussi
    Enrica Baldelli
    Elisa Pellegrini
    Stefano Ballestri
    Dante Romagnoli
    Paola Loria
    [J]. World Journal of Gastroenterology, 2014, (39) : 14185 - 14204
  • [33] Management of nonalcoholic fatty liver disease in the Middle East
    Faisal M Sanai
    Faisal Abaalkhail
    Fuad Hasan
    Muhammad Hamed Farooqi
    Nawal Al Nahdi
    Zobair M Younossi
    [J]. World Journal of Gastroenterology, 2020, 26 (25) : 3528 - 3541
  • [34] Medical management of primary nonalcoholic fatty liver disease
    Sánchez, DM
    [J]. MEDICINA CLINICA, 2005, 125 (03): : 108 - 116
  • [35] Exercise and diet in the management of nonalcoholic fatty liver disease
    Mahady, Suzanne E.
    George, Jacob
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1172 - 1182
  • [36] Role of cenicriviroc in the management of nonalcoholic fatty liver disease
    Neokosmidis, Georgios
    Tziomalos, Konstantinos
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (48) : 5415 - 5417
  • [37] Current management of patients with nonalcoholic fatty liver disease
    Elsheikh, Elzafir
    Henry, Linda L.
    Younossi, Zobair M.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 549 - 558
  • [38] Role of cenicriviroc in the management of nonalcoholic fatty liver disease
    Georgios Neokosmidis
    Konstantinos Tziomalos
    [J]. World Journal of Gastroenterology, 2018, (48) : 5415 - 5417
  • [39] The Nonalcoholic Fatty Liver Disease Activity Score (NAS) and the Histopathologic Diagnosis in Nonalcoholic Fatty Liver Disease: Distinct Clinicopathologic Meanings
    Brunt, E. M.
    Kleiner, D. E.
    Wilson, L. A.
    Belt, P. H.
    Neuschwander-Tetri, B. A.
    [J]. MODERN PATHOLOGY, 2011, 24 : 357A - 358A
  • [40] The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease
    Doumas, Michael
    Imprialos, Konstantinos
    Dimakopoulou, Aikaterini
    Stavropoulos, Konstantinos
    Binas, Athanasios
    Athyros, Vasilios G.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) : 4587 - 4592
12345